课题基金 / 基金详情

ANTISENSE OLIGONUCLEOTIDES AS INHIBITORS OF BREAST & TUMOR-INDUCED ANGIOGENESIS

ANTISENSE OLIGONUCLEOTIDES AS INHIBITORS OF BREAST & TUMOR-INDUCED ANGIOGENESIS
作为乳腺抑制剂的反义寡核苷酸
批准号:
3752792
负责人:
J A LAUTENBERGER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

J A LAUTENBERGER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tumor progression requires the formation of new capillary blood vessels. It is very likely that anti-angiogenesis agents will be effective in preventing the recurrence of metastasis of many types of tumors. We are investigating the role of the ETS1 proto-oncogene in angiogenesis. We have confirmed that expression of this gene in human umbilical vein endothelial cells (HUVECs) is induced by treatment with phorbol myristic acid. We wish to confirm the role of this gene in angiogenesis by examining the effect of antisense oligonucleotides based on the ets sequence on the behavior of endothelial cells. Properties to be monitored include cell proliferation, differentiation, chemotaxis and invasiveness. We also wish to identify other genes involved in angiogenesis by using the differential display technique to isolate cDNAs corresponding to mRNAs that are expressed differentially between endothelial cells treated and not treated with angiogenic agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANALYSIS OF HIV MESSENGER RNA STRUCTURE
IDENTIFICATION OF MOLECULAR MARKERS FOR HUMAN LUNG CANCER
ANTISENSE OLIGONUCLEOTIDES AS INHIBITORS OF TUMOR-INDUCED ANGIOGENESIS
STRUCTURAL, BIOCHEMICAL, AND BIOLOGICAL CHARACTERIZATION OF HIV NEF AND VPU
海外基金